Cargando…
The neuroprotective effects of Chalcones from Ashitaba on cuprizone‐induced demyelination via modulation of brain‐derived neurotrophic factor and tumor necrosis factor α
INTRODUCTION: Multiple sclerosis (MS) is the most common demyelinating disease of the central nervous system. However, the limitations of available therapeutic strategies are frustrating, both in terms of their low efficacy and multiple side effects. Previous studies showed that natural compounds su...
Autores principales: | Rowhanirad, Soodeh, Taherianfard, Mahnaz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10498084/ https://www.ncbi.nlm.nih.gov/pubmed/37403256 http://dx.doi.org/10.1002/brb3.3144 |
Ejemplares similares
-
Brain-Derived Neurotrophic Factor Deficiency Restricts Proliferation of Oligodendrocyte Progenitors Following Cuprizone-Induced Demyelination
por: Tsiperson, Vladislav, et al.
Publicado: (2015) -
A Chalcone from Ashitaba (Angelica keiskei) Stimulates Myoblast Differentiation and Inhibits Dexamethasone-Induced Muscle Atrophy
por: Kweon, Minson, et al.
Publicado: (2019) -
Evaluation of neuroprotective effects of alpha-tocopherol in cuprizone-induced demyelination model of multiple sclerosis
por: Mitra, Nilesh Kumar, et al.
Publicado: (2020) -
Strain differences in cuprizone induced demyelination
por: Yu, Qili, et al.
Publicado: (2017) -
Inhibition of plasminogen activator inhibitor-1 release from human endothelial cells by Angelica keiskei Koidzumi (Ashitaba) chalcones is structure-dependent
por: Ohkura, Naoki, et al.
Publicado: (2015)